Christopher K. Mirabelli
President, DecImmune and Managing Director, Health
Life Science
DecImmune Therapeutics
United States of America
Biography
Dr. Mirabelli joined HealthCare Ventures in 2000 and is a Managing Director at the firm. Dr. Mirabelli was Chairman of the Board and Chief Executive Officer of LeukoSite, Inc. from 1993 through 1999, a company in which HealthCare Ventures was the lead investor. Dr. Mirabelli was also a co-founder of Isis Pharmaceuticals and served with SmithKline and French Laboratories R&D Division. Dr. Mirabelli received his doctorate in molecular pharmacology from Baylor College of Medicine.
Research Interest
Acute inflammation, Irreversible tissue damage, Scar formation, and Loss of tissue functionality.
